Mardepodect - Pfizer
Alternative Names: MP-10; PF-02545920; PF-2545920Latest Information Update: 05 Nov 2023
Price :
$50 *
At a glance
- Originator Pfizer
- Class Antipsychotics; Pyrazoles; Pyridines; Quinolines; Small molecules
- Mechanism of Action Phosphodiesterase 10A inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Huntington's disease; Schizophrenia
Most Recent Events
- 02 May 2017 Discontinued - Phase-I for Huntington's disease (In volunteers) in Sweden (PO) (Pfizer pipeline, May 2017)
- 02 May 2017 Discontinued - Phase-II for Huntington's disease (Early-stage disease) in France (PO) (Pfizer pipeline, May 2017)
- 02 May 2017 Discontinued - Phase-II for Huntington's disease in Canada, United Kingdom, Germany, Poland, USA (PO) (Pfizer pipeline, May 2017)